
Elsin Pharmaceuticals Private Limited
About Elsin Pharmaceuticals Private Limited
Data last updated:
Elsin Pharmaceuticals Private Limited was a private limited company based in Kashipur, Uttarakhand, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the specialised services segment of the trading and commerce sector. It was incorporated on 13 December 2017.
The company was registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2017PTC008318.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Shailendra Singh Rawat and Santosh Rawat.
Its last annual general meeting (AGM) was held on 15 July 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at 7 Achnal Gali Stadium Road R.K Puram, Kashipur, Uttarakhand, India – 244713.
Company details
Contact details
Elsin Pharmaceuticals Private Limited's registered office is in Kashipur, Uttarakhand.
- Registered Address7 Achnal Gali Stadium Road R.K Puram, Kashipur, Uttarakhand, India – 244713
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Elsin Pharmaceuticals Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Elsin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elsin Pharmaceuticals Private Limited
Elsin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Singh Rawat | Director | 13 Dec 2017 | 8 Years 11 Months | As last reported |
| Santosh Rawat | Director | 13 Dec 2017 | 8 Years 11 Months | As last reported |
Legal cases
No court or tribunal cases involving Elsin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elsin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Elsin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Elsin Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Santosh Rawat was appointed as Director on 13 Dec 2017.
Frequently asked questions
Elsin Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Elsin Pharmaceuticals was a private limited company based in Kashipur, Uttarakhand, India. The company worked in specialty, within the trading industry. It was incorporated on 13 December 2017 and is registered under CIN U51909UR2017PTC008318. The company has been struck off by the Registrar of Companies and is no longer operational.
Elsin Pharmaceuticals had 2 directors:
- Shailendra Singh Rawat - Director
- Santosh Rawat - Director
The CIN (Corporate Identification Number) of Elsin Pharmaceuticals is U51909UR2017PTC008318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Elsin Pharmaceuticals is at 7 Achnal Gali Stadium Road R.K Puram, Kashipur, Uttarakhand, India – 244713.
Elsin Pharmaceuticals was incorporated on 13 December 2017. It is registered with the Registrar of Companies, Uttarakhand.
The latest financial statements of Elsin Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 15 July 2020. Year-wise statements from FY 2018 are in the company report.
Elsin Pharmaceuticals operated in the trading industry, in the specialty segment. It worked in this industry before it was struck off.
Santosh Rawat was appointed as Director on 13 Dec 2017. Shailendra Singh Rawat was appointed as Director on 13 Dec 2017.
The compliance status of Elsin Pharmaceuticals is compliant as of 10 September 2026.

